Stay Updated with the Latest Ascendis Pharma A/S ASND News in Real Time
Find ASND news now at Meyka AI. Stay informed with the latest Ascendis Pharma A/S stocks updates, including price news, market analysis, and expert insights.
Honasa Consumer (NSE: HONASA) Falls 4% to ₹403.50 After ₹135 Crore Fluence Pharma Deal
Honasa Consumer shares fell nearly 4% to ₹403.50 after the company announced its ₹135 crore acquisition of a majority stake in Fluence Pharma in June 2026. The deal marks a major step into India’s fast-growing nutraceutical market, expanding beyond traditional beauty and personal care products. While the stock market reacted cautiously, the move highlights Honasa’s…
Aurobindo Pharma (NSE: AUROPHARMA) Shares Slip Despite US FTC Approval for $250 Million Lannett Acquisition
Aurobindo Pharma shares edged lower on June 22, 2026, despite a significant regulatory win announced before market open. Aurobindo Pharma USA, a wholly-owned subsidiary, received approval from the US Federal Trade Commission to proceed with the $250 million acquisition of Lannett Company LLC on a cash-free, debt-free basis. It inclusive of normalized working capital, with…
RTS Swissmedic Fees Rise 35% on July 1, 2026
Swissmedic raises hourly work rate to CHF 270 from CHF 200 effective July 1, 2026, with new medical device registration fees.
Anthem Biosciences Sees ₹1,275 Crore Block Deal as Societe Generale, Prudential Buy 3% Stake
Anthem Biosciences just attracted serious global institutional attention. On June 19, 2026, the Bengaluru-based pharma services company saw a large block deal hit the National Stock Exchange. Global investors led by Societe Generale, Prudential Hong Kong, and Ghisallo Capital Management acquired a combined 3% stake in Anthem Biosciences from promoter Aruna Ganesh for ₹1,275 crore…
Indian Markets End Lower as Nifty 50 Falls 0.64% and Sensex Drops 0.78% Amid IT Selloff
On June 19, 2026, Indian stock markets closed lower. The Nifty 50 slipped 0.64%, while the Sensex fell 0.78%. Selling pressure in IT stocks dragged the benchmarks down. The fall came after a recent rally and weak global tech signals. Investors turned cautious as volatility rose across Dalal Street. It sets a mixed tone for…
Five Nifty Stocks Flash RSI Upswing Signal, June 19
Five Nifty50 stocks show bullish RSI signals on June 17. Sun Pharmaceutical and JSW Steel lead momentum shift as RSI crosses above 50.
Traws Pharma Stock Drops 17% After UK Regulator Delays Flu Drug Trial
One regulatory hold is a setback. Two is a pattern, and Traws Pharma is now facing exactly that. On June 12, 2026, Traws Pharma (NASDAQ: TRAW) announced that its planned Phase 2a human influenza challenge study of tivoxavir marboxil (TXM) has been deferred following a negative review by the UK’s Medicines and Healthcare Products Regulatory…
Analyst Upgrades and Downgrades Today: Focus Stocks AAPL, INTC, NFLX, AMD, OPAD, NVCT, TFPM
Wall Street does not stop moving. Every trading day, analysts at major firms review their positions on stocks and publish fresh rating actions. These analyst upgrades and downgrades directly influence how institutional and retail investors think about a stock. When a top firm shifts its stance on a name like Apple (AAPL) or Intel (INTC),…
Indian Stock Market Week Closing: Sensex Gains 2.30% to 75,527 as Bulls Eye 76K Resistance Zone
The Indian stock market closed the week on a strong bullish note. The Sensex jumped 2.30% to close at 75,527, marking one of the strongest weekly recoveries in recent sessions. The Nifty also followed the upward trend, supported by heavy buying in financial and blue-chip stocks. We saw strong risk-on sentiment across Dalal Street. Global…